Transl oncogenomics
1 – 10 of 60
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
ctDNA as an Objective Marker for Postoperative Residual Disease in Primary Advanced High-Grade Serous Ovarian Cancer
(
- Contribution to journal › Article
-
Mark
Genomic Characteristics Related to Histology-based Immune Features in Breast Cancer
2025) In Modern Pathology : an official journal of the United States and Canadian Academy of Pathology, Inc(
- Contribution to journal › Article
- 2024
-
Mark
The fifth international hackathon for developing computational cloud-based tools and resources for pan-structural variation and genomics
(
- Contribution to journal › Article
-
Mark
Digital PCR quantification of ultrahigh ERBB2 copy number identifies poor breast cancer survival after trastuzumab
(
- Contribution to journal › Article
-
Mark
Proteomic profiling reveals that ESR1 mutations enhance cyclin-dependent kinase signaling
(
- Contribution to journal › Article
-
Mark
Precision Medicine in Breast Cancer: A Molecular Genomics and Diagnostics Approach
2024) In Lund University, Faculty of Medicine Doctoral Dissertation Series(
- Thesis › Doctoral thesis (compilation)
- 2023
-
Mark
Preoperative ctDNA Levels Are Associated With Poor Overall Survival in Patients With Ovarian Cancer
(
- Contribution to journal › Article
-
Mark
CITED1 as a marker of favourable outcome in anti-endocrine treated, estrogen-receptor positive, lymph-node negative breast cancer.
(
- Contribution to journal › Article
-
Mark
Mitochondrial heteroplasmic shifts reveal a positive selection of breast cancer
(
- Contribution to journal › Article
-
Mark
Serum copper, zinc and copper/zinc ratio in relation to survival after breast cancer diagnosis: A prospective multicenter cohort study
(
- Contribution to journal › Article